Scientific Opinion on the safety of 'Chitin-glucan' as a Novel Food ingredient

被引：27

作者：

Agostoni, Carlo Virginio ^{[1
]}

Bresson, Jean-Louis ^{[1
]}

Fairweather-Tait, Susan ^{[1
]}

Flynn, Albert ^{[1
]}

Golly, Ines ^{[1
]}

Korhonen, Hannu ^{[1
]}

Lagiou, Pagona ^{[1
]}

Lovik, Martinus ^{[1
]}

Marchelli, Rosangela ^{[1
]}

Martin, Ambroise ^{[1
]}

Moseley, Bevan ^{[1
]}

Neuhaeuser-Berthold, Monika ^{[1
]}

Przyrembel, Hildegard ^{[1
]}

Salminen, Seppo ^{[1
]}

Sanz, Yolanda ^{[1
]}

Strain, Sean ^{[1
]}

Strobel, Stephan ^{[1
]}

Tetens, Inge ^{[1
]}

Tome, Daniel ^{[1
]}

van Loveren, Hendrik ^{[1
]}

Verhagen, Hans ^{[1
]}

机构：

[1] EFSA, Parma, Italy

来源：

EFSA JOURNAL | 2010年 / 8卷 / 07期

关键词：

Chitin-glucan; novel food ingredient; Kitozyme;

D O I：

10.2903/j.efsa.2010.1687

中图分类号：

TS2 [食品工业];

学科分类号：

0832 ;

摘要：

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to carry out the additional assessment for, Chitin-glucan "as a food ingredient in the context of Regulation (EC) No. 258/97. The Novel Food ingredient called "KiOnutrime-CG (TM)" has a content of more than 90 % chitin-glucan, which is the main component in the cell walls of the mycelium of Aspergillus niger derived from a fermentation process. The compositional data and the manufacturing process do not give rise to concerns. The ingredient is intended to be marketed as a food supplement to increase the daily intake of fibre. The intended intake of chitin-glucan is 2 to 5 g/day. At the highest dose administered in a 13-week rat study, i.e. about 6.6 g/kg body weight (bw), no adverse effects were observed. This dose is approximately 80-fold higher than the maximum intended level of intake for humans on a g/kg bw basis. The Panel concludes that Novel Food KiOnutrime-CG (TM) is safe as a food ingredient at the proposed conditions of use and the proposed intake levels.

引用

页数：17

共 18 条

[1] Scientific Opinion on Dietary Reference Values for carbohydrates and dietary fibre [J].